Lumexa Imaging Holdings, Inc. (LMRI)
10.72
+0.40
(+3.83%)
USD |
NASDAQ |
Oct 05, 13:19
Lumexa Imaging Holdings Enterprise Value : 1.897B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.897B |
| October 01, 2026 | 1.876B |
| September 30, 2026 | 1.890B |
| September 29, 2026 | 1.891B |
| September 28, 2026 | 1.880B |
| September 25, 2026 | 1.887B |
| September 24, 2026 | 1.855B |
| September 23, 2026 | 1.880B |
| September 22, 2026 | 1.916B |
| September 21, 2026 | 1.932B |
| September 18, 2026 | 1.970B |
| September 17, 2026 | 2.012B |
| September 16, 2026 | 2.025B |
| September 15, 2026 | 2.036B |
| September 14, 2026 | 2.000B |
| September 11, 2026 | 2.010B |
| September 10, 2026 | 1.981B |
| September 09, 2026 | 1.989B |
| September 08, 2026 | 2.014B |
| September 04, 2026 | 2.076B |
| September 03, 2026 | 2.049B |
| September 02, 2026 | 2.035B |
| September 01, 2026 | 2.024B |
| August 31, 2026 | 2.027B |
| August 28, 2026 | 2.011B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.033B |
| August 26, 2026 | 2.055B |
| August 25, 2026 | 2.065B |
| August 24, 2026 | 2.044B |
| August 21, 2026 | 2.099B |
| August 20, 2026 | 2.028B |
| August 19, 2026 | 2.044B |
| August 18, 2026 | 2.058B |
| August 17, 2026 | 2.040B |
| August 14, 2026 | 2.060B |
| August 13, 2026 | 2.078B |
| August 12, 2026 | 2.033B |
| August 11, 2026 | 2.026B |
| August 10, 2026 | 2.034B |
| August 07, 2026 | 2.018B |
| August 06, 2026 | 2.005B |
| August 05, 2026 | 1.991B |
| August 04, 2026 | 1.996B |
| August 03, 2026 | 1.987B |
| July 31, 2026 | 1.906B |
| July 30, 2026 | 1.890B |
| July 29, 2026 | 1.895B |
| July 28, 2026 | 1.960B |
| July 27, 2026 | 1.967B |
| July 24, 2026 | 1.956B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| RadNet, Inc. | 7.255B |
| Castle Biosciences, Inc. | 854.73M |
| Quest Diagnostics, Inc. | 31.81B |
| Labcorp Holdings, Inc. | 31.60B |
| OPKO Health, Inc. | 1.261B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.745M |
| Revenue (Quarterly) | 264.16M |
| Total Expenses (Quarterly) | 261.42M |
| EPS Diluted (Quarterly) | 0.0286 |
| Gross Profit Margin (Quarterly) | 11.05% |
| Profit Margin (Quarterly) | 1.04% |
| Earnings Yield | -3.11% |
| Operating Earnings Yield | 2.62% |
| Normalized Earnings Yield | -1.078 |